230 related articles for article (PubMed ID: 29511171)
1. Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties.
Fedele L; Newcombe J; Topf M; Gibb A; Harvey RJ; Smart TG
Nat Commun; 2018 Mar; 9(1):957. PubMed ID: 29511171
[TBL] [Abstract][Full Text] [Related]
2. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
Chen X; Keramidas A; Harvey RJ; Lynch JW
Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
[TBL] [Abstract][Full Text] [Related]
3. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
5. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
[TBL] [Abstract][Full Text] [Related]
6. The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening.
Wells G; Yuan H; McDaniel MJ; Kusumoto H; Snyder JP; Liotta DC; Traynelis SF
Proteins; 2018 Dec; 86(12):1265-1276. PubMed ID: 30168177
[TBL] [Abstract][Full Text] [Related]
7. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
[TBL] [Abstract][Full Text] [Related]
8. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
[TBL] [Abstract][Full Text] [Related]
10. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
[TBL] [Abstract][Full Text] [Related]
11. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
12. Trapping channel block of NMDA-activated responses by amantadine and memantine.
Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
[TBL] [Abstract][Full Text] [Related]
13. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
14. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
15. Synaptic Dysfunction by Mutations in
Elmasri M; Lotti JS; Aziz W; Steele OG; Karachaliou E; Sakimura K; Hansen KB; Penn AC
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741674
[No Abstract] [Full Text] [Related]
16. Characterization of mice carrying a neurodevelopmental disease-associated GluN2B(L825V) variant.
Candelas Serra M; Kuchtiak V; Kubik-Zahorodna A; Kysilov B; Fili K; Hrcka Krausova B; Abramova V; Dobrovolski M; Harant K; Bozikova P; Cerny J; Prochazka J; Kasparek P; Sedlacek R; Balik A; Smejkalova T; Vyklicky L
J Neurosci; 2024 Jun; ():. PubMed ID: 38926089
[No Abstract] [Full Text] [Related]
17. Binding of ArgTX-636 in the NMDA receptor ion channel.
Poulsen MH; Andersen J; Christensen R; Hansen KB; Traynelis SF; Strømgaard K; Kristensen AS
J Mol Biol; 2015 Jan; 427(1):176-89. PubMed ID: 24862283
[TBL] [Abstract][Full Text] [Related]
18. GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms.
Ragnarsson L; Zhang Z; Das SS; Tran P; Andersson Å; des Portes V; Desmettre Altuzarra C; Remerand G; Labalme A; Chatron N; Sanlaville D; Lesca G; Anggono V; Vetter I; Keramidas A
Epilepsia; 2023 Dec; 64(12):3377-3388. PubMed ID: 37734923
[TBL] [Abstract][Full Text] [Related]
19. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
Serraz B; Grand T; Paoletti P
Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor structures reveal subunit arrangement and pore architecture.
Lee CH; Lü W; Michel JC; Goehring A; Du J; Song X; Gouaux E
Nature; 2014 Jul; 511(7508):191-7. PubMed ID: 25008524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]